Jessica Lee Mega MD, MPH

Jessica is the Chief Medical Officer at Verily Life Sciences. She leads Verily’s healthcare team, which informs and studies Verily’s products, creates health platforms, and translates them into systems that improve outcomes. She is a cardiologist who trained and practiced at Massachusetts General Hospital and Brigham and Women’s Hospital.

As a faculty member at Harvard Medical School (on leave) and a senior investigator with the TIMI Study Group, she led large, international, randomized trials evaluating novel cardiovascular therapies. She also directed the TIMI Study Group’s Genetics Program. Jessica has won the Laennec Society, Samuel A. Levine, and Douglas P. Zipes Awards, and she is a Fellow of the American Heart Association and the American College of Cardiology.